Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Editas Medicine, Inc. $90 Million Follow-On Offering

Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $90 million follow-on offering of 4,000,000 shares of common stock…

First BanCorp. Secondary Offering

Davis Polk advised the joint book-running managers and underwriters in a $147.8 million SEC-registered secondary offering of 20,000,000 shares of common stock of First BanCorp., sold by…

Jounce Therapeutics, Inc. Initial Public Offering

Davis Polk advised the lead book-running manager and representative of the underwriters in connection with its $101.9 million initial public offering of common stock of Jounce Therapeutics,…

REV Group $275 million IPO

Davis Polk advised REV Group, Inc. on its $275 million initial public offering of 12,500,000 shares of common stock. The shares of common stock are listed on the New York Stock Exchange…

Loxo Oncology, Inc. Common Stock Offering

Davis Polk advised the joint book-running managers in connection with a $138 million SEC-registered offering of 4,450,500 shares of common stock of Loxo Oncology, Inc. The common stock is…
Back to top